Search Results 1001-1010 of 17700 for Prednisone

  1. Demyelinating disease: What can you do about it? - Mayo Clinic

    Learn the causes and types of these diseases that affect the protective covering of nerves, which include multiple sclerosis.

  2. Felodipine (oral route) - Mayo Clinic

    This can damage the blood vessels of the brain, heart, and kidneys, resulting in a stroke, heart failure, or kidney failure. High blood pressure may also ...

  3. Glycopyrrolate (oral route) - Side effects & dosage - Mayo Clinic

    Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you ...

  4. Study to Evaluate Imetelstat (JNJ-63935937) in Subjects With International Prognostic Scoring System (IPSS) Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS) - Mayo Clinic

    Have received corticosteroids greater than (>) 30 milligram per day (mg/day) prednisone or equivalent, or growth factor treatment within 4 weeks prior to study ...

  5. Mayo Clinic

    Double your impact on cancer! ... Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge. Give Now.

  6. Perindopril and amlodipine (oral route) - Side effects & dosage - Mayo Clinic

    This relaxes the blood vessels and lowers blood pressure. A lower blood pressure will increase the supply of blood and oxygen to the heart. This medicine is ...

  7. A Study Evaluating the Safety and Effectiveness of JCAR017 to Treat Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) - Mayo Clinic

    ... prednisone or equivalent) within 7 days prior to leukapheresis 10. Anti-CD20 monoclonal antibodies within 7 days prior to leukapheresis 11. Venetoclax ...

  8. A Study to Evaluate Effectiveness and Safety of MBG453 in Combination with Azacitidine in Subjects With Intermediate, High or Very High Risk Myelodysplastic Syndrome (MDS), or Chronic Myelomonocytic Leukemia-2 (CMML-2) - Mayo Clinic

    Current use or use within 14 days prior to randomization of systemic steroid therapy (> 10 mg/day prednisone or equivalent) or any immunosuppressive therapy.

  9. Plasma Exchange and Glucocorticoids for Treatment of Anti-Neutrophil Cytoplasm Antibody (ANCA) - Associated Vasculitis - Mayo Clinic

    Treatment with >1 IV dose of cyclophosphamide and/or >14 days of oral cyclophosphamide and/or >14 days of prednisone/prednisolone (>30 mg/day) and/or >1 ...

  10. Education is Key to Pain Medication Safety (pkg)

    Recent upgrades at YouTube have resulted in issues with some older versions of Internet Explorer. If you are only seeing a black box in the player, ...